1-7 of 7
Thomas Davis
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Single Institution Experience of Treating Patients with High Dose Methotrexate for Primary CNS Lymphoma and with Secondary CNS Involvement

Tanya L Lalani, DNP, NP, Ashley D. Staton, MD, Andrew P. Dalovisio, MD, Laura E. Finn, MD, Ambuga Badari, MBBS, Carter Thomas Davis, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 31–32.
https://doi.org/10.1182/blood-2020-141434
Published: 2020
Journal Articles

In Situ Vaccination Improves Efficacy of PD-1 Blockade in Unresponsive Lymphoma Tumors through Induction of a Highly Efficient Cross-Presenting Dendritic Cell Subset Expressing TLR3

Linda Hammerich, Maxime Dhainaut, Tibor Keler, Thomas Davis, MD, Andres M Salazar, Brian D Brown, Joshua Brody, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4106.
https://doi.org/10.1182/blood.V130.Suppl_1.4106.4106
Published: 2017
Journal Articles

Fingolimod Is Cytotoxic in Acute Myeloid Leukemia Independent of Additional Chemotherapeutic Agents

Carter Thomas Davis, MD, Arati V. Rao, MD, Eross Guadalupe, Dale J. Christensen, PhD, J. Brice Weinberg, MD
Journal: Blood
Blood (2016) 128 (22): 5126.
https://doi.org/10.1182/blood.V128.22.5126.5126
Published: 2016
Journal Articles

Lyophilized Platelet Transfusion Does Not Constitute An Immunologic “Second Hit” In a Non-Human Primate Hemorrhagic Shock Model

Alan Anthony Strawn, MD, Paul F Hwang, MD, Thomas Davis, PhD, Eric Elster, MD, Doug Tadaki, PhD, Forest Sheppard, MD
Journal: Blood
Blood (2010) 116 (21): 3360.
https://doi.org/10.1182/blood.V116.21.3360.3360
Published: 2010
Journal Articles

The human anti-CD30 antibody 5F11 shows in vitro and in vivo activity against malignant lymphoma

Peter Borchmann, John F. Treml, Hinrich Hansen, Claudia Gottstein, Roland Schnell, Oliver Staak, Hui-fen Zhang, Thomas Davis, Tibor Keler, Volker Diehl, Robert F. Graziano, Andreas Engert
Journal: Blood
Blood (2003) 102 (10): 3737–3742.
https://doi.org/10.1182/blood-2003-02-0515
Published: 2003
Journal Articles

Phase 1 trial of the novel bispecific molecule H22xKi-4 in patients with refractory Hodgkin lymphoma

Clinical Trials & Observations
Peter Borchmann, Roland Schnell, Irene Fuss, Oliver Manzke, Thomas Davis, Lionel D. Lewis, Detlev Behnke, Claudia Wickenhauser, Petra Schiller, Volker Diehl, Andreas Engert
Journal: Blood
Blood (2002) 100 (9): 3101–3107.
https://doi.org/10.1182/blood-2001-12-0295
Published: 2002
Journal Articles

IDEC-C2B8 (Rituximab) Anti-CD20 Monoclonal Antibody Therapy in Patients With Relapsed Low-Grade Non-Hodgkin's Lymphoma

David G. Maloney, Antonio J. Grillo-López, Christine A. White, David Bodkin, Russell J. Schilder, James A. Neidhart, Nalini Janakiraman, Kenneth A. Foon, Tina-Marie Liles, Brian K. Dallaire, Ken Wey, Ivor Royston, Thomas Davis, Ronald Levy
Journal: Blood
Blood (1997) 90 (6): 2188–2195.
https://doi.org/10.1182/blood.V90.6.2188
Published: 1997